Whimela Shining Implant: Package Insert and Label Information

WHIMELA SHINING IMPLANT- glycerin cream
Threedayslove Co., Ltd.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Glycerin

Water, Niacinamide, Adenosine, Butylene Glycol, etc.

Skin Protectant

keep out of reach of the children

How To Use: Gently shake and spray proper amount to desired area. Also use it frequently onto the dried skin and irritated skin.

Precautions

1. If the cosmetic causes red rash, swollenness or itching by exposure to sunlight during the use, you are advised to stop using it immediately and you may consult a pharmacist or a doctor

2. It is not advised to use the cosmetic on the skin where you have scars

3. Precautions for storage

ⓐ Keep it out of infants or children’s reach

ⓑ Keep it out of the place where exposure to direct sunlight exists

for external use only

1
(click image for full-size original)

WHIMELA SHINING IMPLANT
glycerin cream
Product Information
Product Type HUMAN OTC DRUG Item Code (Source) NDC:72368-0002
Route of Administration TOPICAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
GLYCERIN (GLYCERIN) GLYCERIN 8 g in 100 g
Inactive Ingredients
Ingredient Name Strength
NIACINAMIDE
WATER
BUTYLENE GLYCOL
ADENOSINE
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:72368-0002-1 50 g in 1 JAR None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
OTC monograph final part347 06/01/2018
Labeler — Threedayslove Co., Ltd. (693724138)
Registrant — Threedayslove Co., Ltd. (693724138)
Establishment
Name Address ID/FEI Operations
Threedayslove Co., Ltd. 693724138 manufacture (72368-0002), pack (72368-0002), label (72368-0002)

Revised: 01/2020 Threedayslove Co., Ltd.

DrugInserts.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the US Food and Drug Administration. Package information is not reviewed or updated separately by DrugInserts.com. Every individual package label entry contains a unique identifier which can be used to secure further details directly from the US National Institutes of Health and/or the FDA.

As the leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. Our material is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2020. All Rights Reserved.